您现在位置：健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Antihypertensive Drugs Market Report

健康网讯：

Research Report on Chinese Antihypertensive Drugs Market
Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published:  July 2006 
Format:  Hardcopy and Adobe PDF 
Price:  US$3,100 
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68012929-2008
E-mail: bianch@healthoo.com   wuhf@healthoo.com                      
http://www.healthoo.com


1 Summary
2 Categories and market overview
  2.1 CCB (calcium-channel blocker)
  2.2 ACEI （angiotensin-converting enzyme inhibitor）
  2.3 ARBs (angiotensin Ⅱ receptor blocker)
  2.4 β-blocker
  2.5 α-blocker
  2.6 Diuretic
  2.7 Others
3 Sales analysis of the past 4 years
  3.1 Market scale and growth trend
  3.2 Market share and change trend
    3.2.1 Sales shares of different products of Antihypertensive Drugs
    3.2.2 Sales shares of different products of CCB
    3.2.3 Sales shares of different products of ACEI
    3.2.4 Sales shares of different products of ARBs
    3.2.5 Sales shares of different products of β-blocker
    3.2.6 Sales shares of different products of α-blocker
    3.2.7 Sales shares of different products of diuretic
    3.2.8 Others
  3.3 Change about sales rank of key brands
4 Market analysis of last year
  4.1 Sales shares of different products
  4.2 Sales shares of different brands
  4.3 Key products and competitive enterprises of CCB
    Amlodipine
    Nifedipine
    Felodipine
    Nimodipine
    levamlodipine
    Nitrendipine
    Nisoldipine
    Others
  4.4 Key products and competitive enterprises of ACEI
    Benazepril
    Enalapril
    Captopril
    Lysinopril
    Ramipril
    Compound Captopril
    Others
  4.5 Key products and competitive enterprises of ARBs
    Losartan
    Valsartan
    Irbesartan
    Telmisartan
    Candesartan
    Coumpand preparation
  4.6 Key products and competitive enterprises of β-blocker
  4.7 Key products and competitive enterprises of α-blocker
  4.8 Key products and competitive enterprises of α-blocker
  4.9 Key products and competitive enterprises of Diuretic
5 Sales analysi of key cities
6 Research and development in China
  6.1 Lsit of Domestic marketd products and import procucts
  6.2 Status of application and approval for Blood Thinning Drugs